rivaroxaban
Ligand Summary
A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.
UNII: 9NDF7JZ4M3
PubChem: 9875401
Guide to Pharmacology: 6388
ChEMBL: CHEMBL198362
DrugCentral: 4182
LyCHI: RTBWU7W8TR7W
Target Activities
21 Activities
Items per page:
10
1 – 10 of 21
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
IC50 | ||||||